News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PRC Clinical Completes Over 800 Monitoring Visits In Global Phase 2b Neurology Study


7/8/2014 7:12:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--PRC Clinicalâ„¢, a full-service Contract Research Organization (CRO) headquartered in the San Francisco Bay Area, today announced the completion of over 800 monitoring visits in a global Phase 2b neurodegenerative disease study. The study enrolled more than 700 patients in 73 clinical study sites across 8 countries.

The company provided dedicated trial oversight, site management and monitoring for 56 research centers in the US and Canada including global central laboratory services as well as physical and electronic platform trial master file support.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES